Astrana Health, Inc. Reports Fourth Quarter and Year End 2025 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
ASTH (ASTH) Tops Q4 EPS by 44c, Beats on Revenue; Offers FY26 Revenue Guidance
March 2, 2026 7:06 AM ESTASTH (NASDAQ: ASTH) reported Q4 EPS of $0.54, $0.44 better than the analyst estimate of $0.10. Revenue for the quarter came in at $950.5 million versus the consensus estimate of $930.46 million.
GUIDANCE:
ASTH sees FY2026 revenue of $3.8-4.1 billion, versus the consensus of $3.96... More
